Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.

Rupérez, María; González, Raquel; Mombo-Ngoma, Ghyslain; Kabanywanyi, Abdunoor M; Sevene, Esperança; Ouédraogo, Smaïla; Kakolwa, Mwaka A; Vala, Anifa; Accrombessi, Manfred; Briand, Valérie; +10 more... Aponte, John J; Manego Zoleko, Rella; Adegnika, Ayôla A; Cot, Michel; Kremsner, Peter G; Massougbodji, Achille; Abdulla, Salim; Ramharter, Michael; Macete, Eusébio; Menéndez, Clara; (2016) Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study. PLoS medicine, 13 (2). e1001964-. ISSN 1549-1277 DOI: https://doi.org/10.1371/journal.pmed.1001964

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pmed.1001964

Abstract

Share

Download

Filename: journal.pmed.1001964.PDF

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar